Guanosine promotes myelination and functional recovery in chronic spinal injury

Neuroreport. 2003 Dec 19;14(18):2463-7. doi: 10.1097/00001756-200312190-00034.

Abstract

Functional loss after spinal cord injury (SCI) is caused, in part, by demyelination of axons surviving the trauma. Administration of guanosine (8 mg/kg/day, i.p.) for 7 consecutive days, starting 5 weeks after moderate SCI in rats, improved locomotor function and spinal cord remyelination. Myelinogenesis was associated with an increase in the number of mature oligodendrocytes detected in guanosine-treated spinal cord sections in comparison with controls. These data indicate that guanosine-induced remyelination resulted, at least in part, from activation of endogenous oligodendrocyte lineage cells. These findings may have significant implications for chronic demyelinating diseases.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chronic Disease
  • Female
  • Guanosine / pharmacology*
  • Guanosine / therapeutic use*
  • Motor Activity / drug effects
  • Motor Activity / physiology
  • Myelin Basic Protein / metabolism
  • Myelin Sheath / drug effects
  • Myelin Sheath / metabolism
  • Myelin Sheath / physiology*
  • Nerve Fibers, Myelinated / drug effects
  • Nerve Fibers, Myelinated / metabolism
  • Rats
  • Rats, Wistar
  • Recovery of Function / drug effects*
  • Recovery of Function / physiology
  • Spinal Cord Injuries / drug therapy*
  • Spinal Cord Injuries / metabolism

Substances

  • Myelin Basic Protein
  • Guanosine